Features of modularly assembled compounds that impart bioactivity against an RNA target. - Wikidata - wikimedia - TriplyDB

Features of modularly assembled compounds that impart bioactivity against an RNA target.

Features of modularly assembled compounds that impart bioactivity against an RNA target.

http://www.wikidata.org/entity/Q34986416

about

Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10 Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.Split-and-pool synthesis and characterization of peptide tertiary amide library HIV-1 drug discovery: targeting folded RNA structures with branched peptides.Precise small-molecule recognition of a toxic CUG RNA repeat expansion.Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy.Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics.Structure and Dynamics of RNA Repeat Expansions That Cause Huntington's Disease and Myotonic Dystrophy Type 1.Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA-Targeted Bioactive Ligands.Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.Insights into the development of chemical probes for RNA

P2860

Q28828843-0876558F-DC81-4D6E-8587-114A668BFF62 Q28833658-6F235FA1-248A-47AC-BF99-D13641B630E6 Q30276963-BA2156B5-F87B-404F-A946-441397764254 Q33588831-C3AF6AB8-48D2-42A7-B0E7-67FCE4A66283 Q35201941-1C22B878-35A3-4DD5-84B9-DC845452617F Q35626292-B3201ADB-0081-4592-BCF5-1F88AB5FC733 Q36219835-D50C6B84-C56A-496D-B32F-E12B625B1DDC Q37017309-61FB5462-BCF4-4F72-9137-39B297EC2AA6 Q37358384-24167510-1115-47EB-8187-49CD71A89302 Q37713198-DD0611EA-765D-487A-95CE-B0704F21A8DE Q38287631-0951711A-7302-401B-9408-F2E45D67C8FF Q38430517-B1677DC6-45A5-407E-8E83-ECBE3921A8DC Q38437658-CE66D447-3428-4C91-9183-EE88F142121C Q48236350-BF0AA237-DF68-49F8-AB5F-ABD00DD7B122 Q48263612-D7F93A23-8D56-423D-BE1F-0F86A6CDD9E5 Q58794879-E362182C-9C25-4BD0-A3A9-400F975E3850

P2860

Features of modularly assembled compounds that impart bioactivity against an RNA target.

http://www.wikidata.org/entity/Q34986416

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@ast

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@en

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@nl

type

label

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@ast

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@en

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@nl

prefLabel

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@ast

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@en

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@nl

P1433

Q34986416-2AEFDB48-178B-4CC7-BFEE-9F326F094E06

P1476

Q34986416-4CB2A597-A54B-424A-99B7-15A4ACE9FE68

P2093

Q34986416-5AF457D2-6D3A-4ACD-B796-77976746886D

Q34986416-6F20D0FD-3A84-43A9-8744-E2A2720DF57F

Q34986416-A9ACB6FC-96D8-4976-A803-E7E57B72AA25

Q34986416-ACE67964-ACB2-4A9E-A756-05FD8485CBA9

Q34986416-B89F9A62-98FD-44D4-BAD1-0181F72172F7

Q34986416-FDCB870F-7A00-4C21-8682-2259CFD7A37A

P2860

Q34986416-036BA992-002E-4C73-9B03-B711DEBFA221

Q34986416-0463FCB4-6EE1-473A-96E4-95C8A1288B4A

Q34986416-0485EFD9-9981-44F2-86E3-33CADB124377

Q34986416-04E2BE7E-E1DA-45F3-BAAC-825F00F2D188

Q34986416-0825B5DE-8242-45A0-93B2-444E3E049E09

Q34986416-09FDE3A9-9B2D-48B7-A40F-05C718CCF7F3

Q34986416-0F38EAC1-2785-41CB-96A3-A2BAFD6E7D6B

Q34986416-1157C1FA-92E3-49EF-982A-4851322FE577

Q34986416-16C362CB-D33A-4273-86E8-470F92672D5B

Q34986416-210F2D19-D336-49D8-A3D2-87FE97A9F208

P304

Q34986416-6F4357B5-6FEE-4CD4-A883-8446D44B4632

P31

Q34986416-09997351-FA98-4FA5-A99C-EEE1B5982DCE

P356

Q34986416-92375CEB-9301-42F1-A504-17270B817C4F

P433

Q34986416-3BD74035-E1DD-45B7-B465-5C5B43F5E312

P478

Q34986416-DB9CA8EB-0EC7-4BFB-9AF9-38AF3B7CCCEF

P577

Q34986416-E2BF52ED-64C5-45F5-B4D6-9F6D51F4AEF1

P698

Q34986416-0CE6F2DF-5FB7-4A1A-B881-B9D8BAB472B2

P932

Q34986416-2BDE45E4-3853-446A-89D0-BDFF58F19EF3

P356

P1433

ACS Chemical Biology

P1476

Features of modularly assembled compounds that impart bioactivity against an RNA target.

@en

P2093

Charles A Thornton

http://www.w3.org/2001/XMLSchema#string

Matthew D Disney

http://www.w3.org/2001/XMLSchema#string

Suzanne G Rzuczek

http://www.w3.org/2001/XMLSchema#string

Thomas Kodadek

http://www.w3.org/2001/XMLSchema#string

Yu Gao

http://www.w3.org/2001/XMLSchema#string

Zhen-Zhi Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy

Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Direct inhibition of the NOTCH transcription factor complex

Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1

NMR spectroscopy and molecular dynamics simulation of r(CCGCUGCGG)₂ reveal a dynamic UU internal loop found in myotonic dystrophy type 1.

Myotonic Dystrophy Type 1 RNA Crystal Structures Reveal Heterogeneous 1 × 1 Nucleotide UU Internal Loop Conformations

The bacterial ribosome as a target for antibiotics

A muscleblind knockout model for myotonic dystrophy

Pre-mRNA splicing and human disease

P304

2312-2321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/CB400265Y

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24032410

http://www.w3.org/2001/XMLSchema#string

P932

3876286

http://www.w3.org/2001/XMLSchema#string